Literature DB >> 28839726

Pouchitis: a practical guide.

A Hillary Steinhart1, Ofer Ben-Bassat1.   

Abstract

Up to 30% of patients with ulcerative colitis (UC) will require surgical management. The established surgical procedure of choice is colectomy with ileal pouch-anal anastomosis (IPAA) for most patients. Patients with UC who have undergone IPAA are prone to develop inflammatory and non-inflammatory complications. Up to 50% of patients can be expected to experience at least one episode of pouchitis, and most of these patients will experience at least one additional acute episode within 2 years. In other cases, pouchitis might follow a relapsing-remitting course or a chronically active course. The specific aetiology of pouchitis is unknown and the optimal means of diagnosis and classification of pouchitis is not completely agreed upon. Diagnosis of pouchitis based on symptoms alone has been shown to be non-specific due to the fact that symptoms can originate from a myriad of aetiologies, not necessarily inflammatory in nature. As a result, the diagnosis of pouchitis should generally be based on the appropriate constellation of symptoms, combined with endoscopic and histological assessment. Due to the frequently relapsing course of pouchitis, and the fact that the aetiology and pathogenesis are not entirely clear, the long-term management can sometimes be challenging. This review outlines the features suggestive of deviation from 'normal' pouch function and provides an approach to the optimal use of diagnostic modalities and medical therapies to treat pouchitis in its various forms.

Entities:  

Keywords:  Ibd Clinical; Ibd Surgery; Pouchitis; Ulcerative Colitis

Year:  2013        PMID: 28839726      PMCID: PMC5369791          DOI: 10.1136/flgastro-2012-100171

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  22 in total

1.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis.

Authors:  Bo Shen; Victor W Fazio; Feza H Remzi; Ana E Bennett; Rocio Lopez; Aaron Brzezinski; Ioannis Oikonomou; Kerry K Sherman; Bret A Lashner
Journal:  Dis Colon Rectum       Date:  2007-04       Impact factor: 4.585

3.  Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study.

Authors:  P Wischmeyer; J H Pemberton; S F Phillips
Journal:  Mayo Clin Proc       Date:  1993-10       Impact factor: 7.616

4.  Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

Authors:  P Gionchetti; F Rizzello; A Venturi; F Ugolini; M Rossi; P Brigidi; R Johansson; A Ferrieri; G Poggioli; M Campieri
Journal:  Aliment Pharmacol Ther       Date:  1999-06       Impact factor: 8.171

5.  Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA.

Authors:  Liam A Haveran; Rishabh Sehgal; Lisa S Poritz; Kevin J McKenna; David B Stewart; Walter A Koltun
Journal:  Dis Colon Rectum       Date:  2011-01       Impact factor: 4.585

6.  Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis.

Authors:  B Shen; J P Achkar; B A Lashner; A H Ormsby; F H Remzi; C L Bevins; A Brzezinski; R E Petras; V W Fazio
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

7.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

8.  Clinical guidelines for the management of pouchitis.

Authors:  Darrell S Pardi; Geert D'Haens; Bo Shen; Simon Campbell; Paolo Gionchetti
Journal:  Inflamm Bowel Dis       Date:  2009-09       Impact factor: 5.325

9.  Leukocytapheresis for the treatment of active pouchitis: a pilot study.

Authors:  Yasumi Araki; Keiichi Mitsuyama; Takaaki Nagae; Yuji Tou; Motonori Nakagawa; Yasue Iwatani; Masakazu Harada; Hiroyuki Ozasa; Michio Sata; Toshihiro Noake
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

10.  Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial.

Authors:  W J Tremaine; W J Sandborn; B G Wolff; H A Carpenter; A R Zinsmeister; P P Metzger
Journal:  Aliment Pharmacol Ther       Date:  1997-12       Impact factor: 8.171

View more
  2 in total

1.  Pouch dysfunction: don't forget the surgeons!

Authors:  David N Naumann; Sian Abbott; Diane Hall; Douglas M Bowley
Journal:  Frontline Gastroenterol       Date:  2013-07-18

2.  Mucosa-Associated Microbiota in Ileoanal Pouches May Contribute to Clinical Symptoms, Particularly Stool Frequency, Independent of Endoscopic Disease Activity.

Authors:  Williams Turpin; Orlaith Kelly; Krzysztof Borowski; Karen Boland; Andrea Tyler; Zane Cohen; Kenneth Croitoru; Mark S Silverberg
Journal:  Clin Transl Gastroenterol       Date:  2019-05-22       Impact factor: 4.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.